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The requirement for a miniature, high density, long life, and rechargeable power source 
is common to a vast majority of microsystems, including the implantable devices for 
medical applications. A model biofuel cell system operating in human serum has been 
studied for future applications of biomedical and implantable medical devices. Anodic 
and cathodic electrodes were made of carbon nanotube-buckypaper modified with 
PQQ-dependent glucose dehydrogenase and laccase, respectively. Modified electrodes 
were characterized electrochemically and assembled in a biofuel cell setup. Power 
density of 16.12 μW cm−2 was achieved in human serum for lower than physiological 
glucose concentrations. Increasing the glucose concentration and biofuel cell tempera-
ture caused an increase in power output leading up to 49.16 μW cm−2.
Keywords: biofuel cell, power production, laccase, PQQ-dependent glucose dehydrogenase, human serum, 
implantable medical device
inTrODUcTiOn
The power requirements are one of the key limiting factors for implantable electronic devices as well 
as all portable and autonomous electronic systems. Although secondary power cells (e.g., lithium 
ion) can still be developed to improve on the existing state of the art, biofuel cells introduce a break-
through concept as recharging can be theoretically achieved with virtually any available biomaterial. 
Biofuel cells can enable a permanent implantation without the need for surgical replacement, which 
clearly strengthens the community’s competence in this area.
Recently, the possibility of developing implantable enzymatic biofuel cells (EBFCs) has come 
into focus since these devices would serve as a low-power source to miniature systems within the 
human body. EBFCs employ glucose as the substrate and oxygen or hydrogen peroxide as oxidizers, 
in which the power is gained by an oxidation of the biofuel at the anode (Figure 1). The enzymes 
involved in the process are usually glucose oxidase (GOx), horseradish peroxide (HPR), bilirubin 
oxidase (BOD), and laccase among the others (Willner et al., 1998; Pizzariello et al., 2002; Mano 
et al., 2003a,b). The human body is a storehouse of energy. An average person of 68 kg with 15% 
body fat stores energy approximately equivalent to 384540 kJ (Starner and Paradiso, 2004). However, 
the body has an abundant supply of energy from the food that we eat. For example, the power 
consumption of the brain is approximately 0.29 kcal/min (about 20 W) (Angel, 1990). Thus, if even 
a small fraction of this stored energy could be scavenged, an electronic device would have a large 
and renewable resource to draw on (Starner and Paradiso, 2004). This may be accomplished through 
the use of the energy stored within chemicals present in biological fluids, such as glucose (Barrière 
et al., 2004).
FigUre 1 | Functionalized MWcnT-buckypaper-based biofuel cell 
operating in human serum from human male aB plasma. 
Bioelectrocatalytic reactions are based on the glucose oxidation by the 
PQQ-GDH and H2O2-reduction by laccase at anode and cathode, 
respectively.
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A variety of electron mediators can be used for the electrical 
contacting of the biocatalysts and the electrodes. The function-
alization of the electrode surfaces with assembled monolayers 
of redox enzymes, electrocatalysts, and bioelectrozymes (i.e., 
genetically engineered biocatalysts) (Güven et al., 2010; Yu et al., 
2011) can lead to very effective electrical contact (Willner et al., 
1998). However, most of these systems would involve the use 
of diffusional mediators which are dissolved in their respective 
compartments, and this poses an additional problem for the 
devices that are intended to be used as power sources for implant-
able medical devices. Bioelectrocatalytic electrodes, providing 
efficient non-mediated electric wiring for immobilized enzymes, 
must be simple in fabrication and stable in electrochemical reac-
tion. A physiological biofuel cell-powered device is in need of 
constant, reliable, long-term power provided by a body-based 
biofuel. First in vivo trials with fuel cells, implanted subcutane-
ously in right flank of adult dog, yielded a power density per-
formance of 2 μW cm−2 (Drake et al., 1970) and in a rat (Wan 
and Tseung, 1974), which was generating 2.9 μW cm−2 of power 
for a time period of at least 4 h. Although, these earlier results 
were encouraging with respect to the electricity produced for 
low-power medical implants, preliminary studies were operated 
with abiotically catalyzed glucose rather than bioelectrocatalyst 
reactions. With the aim of developing an EBFC operating in vivo, 
researchers demonstrated power production from the hemo-
lymph of snails (Halámková et  al., 2012), “cyborg” lobsters 
(MacVittie et al., 2013), and serially connected clams (Szczupak 
et  al., 2012). In addition, a biofuel cell was placed in an insect 
(Rasmussen et al., 2012). Although first animal experiments were 
not performed with mammals, studies demonstrated that EBFCs 
can produce electricity out of living organisms.
Toward human implantable applications, the first demonstra-
tion of an implanted biofuel cell (fully biological), generating 
electricity inside a living organism and, in particular, implanted 
in a mammal, was in a rat (Cinquin et al., 2010). It was reported 
that the biofuel cell is able to generate electric power in a rat, 
using glucose and oxygen contained in its body fluids with an 
open circuit potential (OCP) of 0.275 V and maximum power 
output of 6.5 μW (Cinquin et  al., 2010). Then, more sturdily 
constructed biofuel cell prototype was partially (anode com-
partment only) implanted in rabbit ear (Miyake et  al., 2011), 
which was reflected in the maximum cell current (1.50 μA), 
whereas the power of this cell reached 0.42 μW at 0.56 V and 
in brain of a living rat with a maximum power of 2 μW cm−2 
at a cell voltage of 0.4 V (Andoralov et  al., 2013). Later, with 
the recent improvements in terms of carbon nanotube (CNT) 
compression and direct electron transfer, researchers were 
successful to increase the power (38.7  μW) obtained from 
the implanted biofuel cell in a rat, using a specially designed 
electronic circuit to charge a capacitor, to run a LED, or a 
digital thermometer (Zebda et al., 2013). Recently, researchers 
reported a glucose/oxygen biofuel cell using FAD-dependent 
glucose dehydrogenase enzyme at the anode side operating in 
human serum, which produces maximum power densities of 
39.5 ± 1.3 and 57.5 ± 5.4 μW cm−2 for EFCs at 21 and 37°C, 
respectively (Milton et al., 2015).
In our study, the strategy of direct electrochemical com-
munication has been successfully applied with nanostructured 
buckypaper composed of multi-wall CNTs (Narváez Villarrubia 
et al., 2011; Strack et al., 2011; Halámková et al., 2012; MacVittie 
and Katz, 2014). Enzymes were immobilized onto buckypaper 
by using a heterobifunctional cross-linker, 1-pyrenebutanoic 
acid succinimidyl ester (PBSE), which provides covalent bind-
ing with amino groups of protein lysine residues through the 
formation of amide bonds and interacts with CNTs via π–π 
stacking of the polyaromatic pyrenyl moieties (Strack et al., 2011). 
PBSE results in a random orientation of the enzyme molecules 
relative to the electrode surface because of the large number of 
amino acid groups randomly positioned in the protein structure 
(Katz, 1994). In the case of a flat, robust electrode surface, direct 
electrode transfer would not be possible because active centers 
are buried inside the enzymes and therefore would be far away 
from the transducer surface (Katz, 1994). However, in the case 
of a buykypaper, electron access channels of the enzymes can 
find closer electron transport pathways regardless of the enzyme 
orientation, allowing efficient communication between the CNTs 
and the enzyme. Selection of the enzymes to immobilize on the 
buckypaper is also an important issue. In this study, pyrroloqui-
noline quinone-dependent glucose dehydrogenase (PQQ-GDH) 
was selected for the anodic bioelectrode because of the successful 
bioelectrocatalytic generation of anodic currents in the presence 
of glucose, when enzyme is tethered to CNT materials (Strack 
et al., 2013). Eventually, a dehydrogenase-based anode operating 
in the presence of oxygen did not require complex molecular 
ensemble to achieve a kinetically preferred electron transfer to 
the bioelectrode instead of oxygen (Katz et al., 1999). In order 
to perform potentially favorable biofuel cell operation based on 
glucose oxidation and oxygen reduction at the anode and cathode 
electrodes, respectively, oxygen-reducing laccase was selected for 
the cathodic reaction. Laccase is a well-known biocatalyst that is 
commonly used in EBFCs (Calabrese Barton et al., 2004), and it is 
compatible with the buckypaper electrode (Hussein et al., 2011).
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In this study, a model system is demonstrated for the biofuel 
cells that are operated in human serum. After the preliminary 
attempts to address the problems of integrated circuitries in a 
biofuel cell setup, with systems mimicking human physiology 
(Coman et al., 2010; Southcott et al., 2013), cyclic voltammetry 
and biofuel cell polarization that were applied for the characteri-
zation of the power generated from human serum is presented 
in this study.
MaTerials anD MeThODs
enzyme Preparation
Pyrroloquinoline quinone-dependent glucose dehydrogenase 
(E.C. 1.1.5.2) from Microorganism (Toyobo Co., Japan) was used 
as supplied. Laccase (E.C. 1.10.3.2, from Trametes versicolor) was 
obtained from Sigma-Aldrich and used in experiments after the 
purification method as described elsewhere (Strack et al., 2011). 
Briefly, laccase was dissolved (5  mL, 20  mg  mL−1) in potas-
sium phosphate buffer (20  mM, pH 7.3) and dialyzed using a 
Slide-A-Lyzer dialysis cassette (10 kDa molecular weight cutoff; 
Thermo Fisher Scientific, Inc.) against a series of sequential 
buffer exchanges (10 mM potassium phosphate, pH 7.0 for 12 h 
at 4°C) containing 1 mM CuSO4, 1 mM EDTA, and buffer only. 
Following dialysis, the protein concentration of the preparation 
was determined using a bicinchoninic acid protein assay kit 
(Thermo Fisher Scientific, Inc.). Protein activity in respect to 
catalytic oxidation was determined for syringaldazine, using 
the supplier’s standard method (Sigma-Aldrich). The laccase 
preparation was normalized to a defined protein concentration 
(1.5 mg mL−1).
electrode Preparation
Carbon nanotube-buckypaper prepared from 100% multi-walled 
CNTs (Buckeye Composites; NanoTechLabs, Yadkinville, NC, 
USA) was used as the electrode material (0.25  cm2 geometric 
area). Electrodes were incubated with 10  mM PBSE (AnaSpec 
Inc.) in DMSO with moderate shaking for 1 h at room temperature 
(RT) and subsequently rinsed in DMSO (5 min) to remove excess 
PBSE and then in potassium phosphate buffer (10 mM, pH 7.0; 
5  min). The PBSE-functionalized electrodes were immediately 
incubated with enzyme solutions, for 1 h at RT with moderate 
shaking, before washing extensively with potassium phosphate 
buffer (10 mM, pH 7.0). Enzyme solutions consist of 1 mg mL−1 
PQQ-GDH dissolved in potassium phosphate buffer (10 mM, pH 
7.0) supplemented with 1 mM CaCl2 and 1.5 mg mL−1 of purified 
laccase for the modification of anode and cathode, respectively. 
The activity of PQQ-GDH and laccase immobilized on the anode 
and cathode were reported as 250 and 460  mU per electrode, 
respectively (Halámková et al., 2012), by performing optical assays 
as described elsewhere (Holwerda and Gray, 1975; Dewanti and 
Duine, 1998). The modified electrodes were used immediately or 
stored (4°C) in potassium phosphate electrolyte (0.1M, pH 7.0) 
until used in biofuel cell or electrochemical measurements.
electrochemical Measurements
Enzyme (PQQ-GDH or laccase) and cross-linker (PBSE)-
modified buckypaper electrodes were connected through a 
copper conductive tape (3M, SPI supplies) to a potentiostat (ECO 
Chemie Autolab PASTAT 10 electrochemical analyzer, using the 
GPES 4.9 software package) and used as the working electrode 
in electrochemical measurements where a Pt wire (Metrohm) 
and a Ag|AgCl|KCl 3M (Metrohm) were used as counter and 
reference electrodes, respectively. Cyclic voltammograms (CVs) 
were obtained in the potential range between 0 and 0.8  V (vs. 
Ag/AgCl) at a scan rate of 1  mV  s−1. CVs of bioanode were 
tested in sterile-filtered human serum from human male AB 
plasma (Sigma-Aldrich, Product# H4522) supplemented with 
glucose (19.89 mM, final concentration) and a no glucose buffer 
solution (22  mM NaHCO3, 40  mg  mL−1 BSA, 6.7  mM MgCl2, 
5 mM KCl; pH 7.4) mimicking in vitro physiological conditions 
(Roach, 1963), whereas biocathode measurements were achieved 
in the absence and presence of oxygen (in equilibrium with air). 
Anaerobic conditions were achieved by purging the solution with 
nitrogen.
Biofuel cell Measurements
The electrodes were modified for the biofuel cell measurements 
as it is explained above. Biocatalytic electrodes were assembled 
in human serum solutions. Glucose concentration of the human 
serum used in this study is 4.89 mM (Ammam and Fransaer, 2010; 
Ammam and Easton, 2011). The effect of glucose concentration 
on power output was measured by adding d-glucose (from 4.89 to 
24.89 mM, final concentration) into human serum solution. The 
voltage and current generated by the biofuel cell were measured 
by a digital multimeter (Meterman 37XR). For the determination 
of the power output, a variable resistance was used as an external 
load. The measurements were carried out at ambient temperature 
(23 ± 2°C). In order to evaluate the performance of the biofuel 
cell for in vivo use, it was tested in human serum at 37°C.
resUlTs anD DiscUssiOn
The biofuel cell anode was characterized using CVs to validate 
whether the functionalized biocatalytic buckypaper electrodes 
(0.25 cm2) are capable of electron transfer to the electrodes. Peaks 
in the voltage–current curves would be observed at potentials 
corresponding to the potentials of the enzyme active centers, such 
as PQQ and T1 in GDH (Katz et al., 1999) and laccase (Calabrese 
Barton et al., 2004), respectively, in order to confirm the direct 
electrochemistry between the enzyme active center and electrode 
surface.
Cyclic voltammograms of the PQQ-GDH-modified elec-
trodes were obtained in human serum supplemented with 
glucose (24.89 mM, final concentration) (Figure 2, blue curve) 
and in mimicking solution free of glucose (Figure 2, red curve). 
The anodic currents produced by PQQ-GDH (Figure  2) were 
observed only in the presence of glucose, which shows the suc-
cessful immobilization of PQQ-GDH onto PBSE-functionalized 
CNT-buckypaper electrode. The anodic current produced by 
the oxidation reaction of the PQQ-GDH electrode was devel-
oped at around 0.10–0.15 V vs. Ag/AgCl. Previous works have 
reported that the anodic current produced by the PQQ-GDH 
electrode appeared at potentials more positive than −0.1 V vs. 
Ag/AgCl in  a solution mimicking the physiological conditions 
FigUre 2 | cVs of the PQQ-gDh anode in human serum 
supplemented with 20.89 mM glucose (blue) and glucose-free 
mimicking solution (red).
FigUre 3 | cVs of laccase cathode in human serum in the presence 
(blue) and absence (red) of oxygen.
TaBle 1 | summary of the biofuel cell performance results obtained from 
different human serum samples.
OcP (V) Maximum power (μW)
Serum 0.286 4.03
Serum + 5 mM glucose 0.336 6.28
Serum + 10 mM glucose 0.388 9.04
Serum + 15 mM glucose 0.413 11.50
Serum + 20 mM glucose 0.436 12.29
Serum at 37°C 0.396 8.27
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(Halámková et al., 2012). The anodic voltage obtained in human 
serum approximately correspond the values demonstrated in 
buffer solutions for similar electrodes. Therefore, this result can 
be interpreted as the electrochemical activity of bioelectrodes. 
A positive correlation between the glucose concentration and 
bioelectrocatalytic current (data not shown) reveals the role of 
the glucose oxidation reaction as a significant source of electrons. 
The cathodic reaction of laccase-modified electrode is shown in 
Figure 3. The presence of oxygen in human serum clearly resulted 
in the formation of bioelectrocatalytic currents (Figure  3, 
blue curve) where the oxygen reduction peak starts at around 
0.50–0.55 V vs. Ag/AgCl. The appearance of the cathodic current 
obtained in human serum is similar to the previously reported 
currents appearing at ca. 0.58  V vs. Ag/AgCl in other related 
systems (Strack et al., 2011; Halámková et al., 2012).
The cell electromotive force (EMF) is the potential dif-
ference between the anode and the cathode or the voltage of 
the electrochemical cell. Theoretically, open circuit potential 
(OCP) should be the difference between anodic and cathodic 
potentials, i.e., EMF; however, in practice, the OCP is substan-
tially lower than the theoretical value due to various potential 
losses, particularly activation/kinetic loss. The anodic and 
cathodic potential, obtained by the PQQ-GDH and laccase 
electrodes, were produced at 0.1 and 0.55  V vs. Ag/AgCl, 
respectively. Therefore, the OCP of ca. 0.45  V between the 
reactions at the anode and the cathode can be obtained.
After demonstrating the electrochemical activity of biocata-
lytic oxidation and reduction reactions, electrodes were used for 
harvesting electrical power from human serum in  vitro. The 
overall performance of the biofuel cell is evaluated by its power 
output. Power is calculated as
 P i E= × cell  
(1)
To evaluate the power generation, a decreasing resistance from 
300 kΩ to 100 Ω at a time interval of 10 s in each load was applied, 
and the current and cell potentials for each resistance were meas-
ured. Later, the applied resistor, cell potential, and current were 
used to calculate power. Therefore, it can be said that power gener-
ated by biofuel cell was computed as a product of current passing 
through an external load and voltage drop across the resistor.
The results of the different biofuel cell measurements operating 
in human serum and different additions of glucose concentrations 
are summarized in Table 1. The purpose of this experiment was 
to demonstrate the EBFC operation under different physiologi-
cal conditions representing different glucose concentrations in 
human blood. With an attempt to demonstrate the biofuel cell in 
biomedical applications, human serum solution was spiked with 
various concentrations of glucose. Thus, final glucose concentra-
tions between 4.89 and 24.89 mM were realized, corresponding to 
various physiological conditions (i.e., diabetes mellitus and health 
ranges) (Nelson et al., 2008). The biofuel cell operated in human 
serum showed an OCP value of 286 mV, and it was observed that 
upon an increase of the load resistance, the recorded power from 
human serum increased up to a maximum net value of 4.03 μW 
(power density of 16.12 μW cm−2) at an external load of 10 kΩ. 
The OCPs of the other human serum samples showed increas-
ing values with increasing glucose concentrations as well as the 
power output, in which the maximum OCP and power density 
were 436 mV and 12.29 μW (power density of 49.16 μW cm−2), 
respectively.
Figures 4 and 5 show the cell voltage as a function of current 
density, also known as the polarization curve of the biofuel cell, 
and the power output of the biofuel cell operating in human 
serum and different glucose additions, respectively. The power 
FigUre 5 | The power output of the fuel cell operating in human 
serum and different glucose additions, at room temperature.
FigUre 4 | cell voltage vs. current density curve of the biofuel cell 
operating in human serum and different glucose additions, at room 
temperature.
FigUre 6 | Maximum produced power by the biofuel cell as a function 
of the glucose concentration at external load of 10 kΩ.
FigUre 7 | Temperature dependence of the power output of the 
biofuel cell operating in human serum at rT (blue) and 37°c (red).
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generation from biofuel cell reached its maximum values where 
external resistance was equal to internal resistance (Menicucci 
et al., 2006), on the load of 10 kΩ followed by a gradual decay due 
to mass transport losses as the external load is increased, indica-
tive of typical fuel cell behavior (Bockris and Srinivasan, 1969). 
At high current density values, the reaction is limited by mass 
transport of reactants. In most of the cases, it is a sharp decrease 
of the voltage to 0 at the certain current density value or around it 
as seen in our data for lower glucose concentrations. With higher 
glucose concentrations, after peak power is achieved, it was pos-
sible to continue polarizing the cell until the voltage dropped to a 
low value of 0.05 at 20 mM glucose. Further polarizing the cell did 
not increase current density as voltage dropping, a bend back on 
polarization curve, can be observed due to mass transport limita-
tion. This is common in biological fuel cells known as “power 
overshoot.”
The shapes of power curves for elevated sugar values in this 
model system were almost identical where the maximum power 
output was obtained with different glucose concentrations at the 
optimum external load of 10 kΩ. Since the variations at power 
generation represent the current/voltage dependence on the 
glucose (Castorena-Gonzalez et  al., 2013), obtained net power 
has increased from 4.03 to 12.29 μW when the glucose levels were 
increased from 4.89 to 24.89 mM. However, linearity between the 
power output and glucose concentration was achieved between 
4.89 and 19.89 mM (final concentrations) as the saturation level 
of the glucose concentration was reached for the biofuel cell 
operation. Figure  6 shows the maximum power generation by 
the biofuel cell as a function of the glucose concentration at the 
external load of 10  kΩ. The glucose-sensitive (0.50  μW/mM) 
biofuel cell is a redox pair of electrodes that generates power 
proportional to glucose concentration. Such a system can achieve 
simultaneous power transmission to implantable glucose sensors 
(Rai and Varadan, 2012) that measure real-time blood glucose as 
compared to conventional techniques involving drawing blood 
samples and in vitro processing.
The temperature dependence of the biofuel cell operating in 
human serum at RT and at 37°C was examined without further 
optimization of the system. The power output showed sensitivity 
against temperature, and the power production has increased 
up to 8.27 μW at 37°C, which is almost twofold higher than it 
is recorded at RT (Figure 7). Moreover, not only similar power 
curve behavior was observed at 37°C but also with applying an 
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external load of 10 kΩ, the biofuel cell produced electrical power 
demonstrated a relatively long period of stability (at least 3 h) at 
37°C, with no medium replacement during the entire experiment. 
However, the problem about whether the enzymes remain stable 
for a long period of time is a concern. The efficiency of electron 
transfer between enzymes and electrodes should be improved.
The enhancement on power output at human body tempera-
ture makes biofuel cell operating in human serum an attractive 
development prospect for use in future applications where power 
is needed for implantable medical devices.
cOnclUsiOn
In this study, a model enzymatic fuel cell was developed CNT-
buckypaper with PQQ-GDH on the anode for glucose oxidation 
and laccase on the cathode for oxygen reduction. The maximum 
OCP and power density were obtained as 0.44 V and 12.29 μW 
(power density of 49.16 μW cm−2), respectively. Additional studies 
for electrochemical characterization of enzyme-immobilized 
buckypaper electrodes have been achieved. Current studies are 
underway for further identification of the operational stability of 
the energy production process but what is undeniable is the proof 
of principle that human serum can be used as an energy source 
for biofuel cells.
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